Biological activity of methyl 2-[5-oxo-3,4-di-(2-pirydyl)- 1,4,5,6-tetrahydro-1,2,4-triazine-6-ylidene] acetate

Acta Poloniae Pharmaceutica - Drug Research

Volumn 65, Issue 6, 2008, Pages 789-791

  Ucherek, Marzena M ^a   Wróblewska, Joanna ^a   Modzelewska Banachiewicz, Bozena ^a   Gospodarek, Eugenia ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

5 oxo 1,4,5,6 tetrahydro 1,2,4 triazine derivatives; Antifungal activity; Antimicrobial activity

Indexed keywords

METHYL 2 [5 OXO 3,4 DI(2 PIRYDYL) 1,4,5,6 TETRAHYDRO 1,2,4 TRIAZIN 6 YLIDENE]ACETATE; TRIAZINE DERIVATIVE; UNCLASSIFIED DRUG; ACETIC ACID DERIVATIVE; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; METHYL 2 (5 OXO 3,4 DI (2 PYRIDYL) 1,4,5,6 TETRAHYDRO 1,2,4 TRIAZINE 6 YLIDENE)ACETATE; METHYL 2-(5-OXO-3,4-DI-(2-PYRIDYL)-1,4,5,6-TETRAHYDRO-1,2,4-TRIAZINE-6-YLIDENE)ACETATE;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CHEMICAL REACTION; DRUG SENSITIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; CANDIDA; DRUG EFFECT; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MICROBIOLOGICAL EXAMINATION;

ACETATES; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; CANDIDA; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; TRIAZINES;

EID: 61549115600     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. The Merck Index & Co. Inc., Whitehouse Station, NJ, USA; 9935 (2006).
2. The Merck Index & Co. Inc., Whitehouse Station, NJ, USA; 726 (2006).
3. The Merck Index & Co. Inc., Whitehouse Station, NJ, USA, 5353 (2006).
4. The Merck Index & Co. Inc., Whitehouse Station, NJ, USA, 1953 (2006).
5. The Merck Index & Co. Inc., Whitehouse Station, NJ, USA, 904 (2006).
6. The Merck Index & Co. Inc., Whitehouse Station, NJ, USA, 7950 (2006).
7. Ausborn, J., Wolf H., Mader W., Kayser H.: J. Exp. Biol. 208, 4451 (2005).
8. Hegde J.C., Girisha K.S., Adhikari A., Kalluraya B.: Eur. J. Med. Chem. (2008; in press); doi:10.1016/j.ejmech.2008.02.003.
9. Taha A.M.: Monatsh. Chem. 138, 505 (2007).
10. Mamolo M.G., Falagiani V., Zampieri D., Vio L., Banfi E.: Farmaco 55, 590 (2000).
11. Diana P., Matowana A., Barraja P., et al.: Bioorg. Med. Chem. 15, 343 (2007).
12. Sztanke K., Pasternak K., Rzymowska J., Sztanke M., Kandafer- Szerszeń M., Dybała I., Kozioł A. E.: Bioorg. Med. Chem. 15, 2837 (2007).
13. El Gendy Z., Morsy J.M., Allimony, H.A., Ali, W.R., Abdel-Rahman, R.M.: Pharmazie 56, 376 (2001).
14. Abdel-Rahman R.M., Morsy J.M., El-Edfawy S., Amine H.A.: Pharmazie 54, 667 (1999).
15. Abdel-Rahman R.M., Morsy J.M., Hanafy F., Amene H.A.: Pharmazie 54, 347 (1999).
16. Russel M.G.N., Carling R.W., Street L.J., et al.: J. Med. Chem. 49, 1235 (2006).
17. Koek W., Patoiseau J.-F., Assie M.-B., et al.: J. Pharmacol. Exp. Ther. 287, 1 (1998).
18. Modzelewska-Banachiewicz B., Ka=abun J.: Pharmazie 54, 503 (1999).
19. Modzelewska-Banachiewicz B., Kowalski C., Ziü=kowska G., Banachiewicz J.: Ann. UMCS sec. DD 60, 2 (2005).
20. Modzelewska-Banachiewicz B., Szcześniak Z.: Ann. UMCS sec. DDD 14, 1 (2001).
21. Truchliòski J., Kifer-Wysocka E., Modzelewska-Banachiewicz B.: Ann. UMCS sec. D 60, 6 (2000).
22. Modzelewska-Banachiewicz B., Kamìska T.: Eur. J. Med. Chem. 36, 93 (2001).
23. Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement. CLSI M100-S16 (M2-A9 and M7-A7), January 2006.
24. Ortega E., Algarra I., Serrano M.J., de Pablo M.A., Alvares de Cienfuegos G., Gaforio J.J.: FEMS Immunol. Med. Microbiol., 28, 283 (2000).
25. Cernicka J., Kozovska Z., Hnatova M., et al.: Int. J. Antimicrob. Agents 29, 170 (2007).